Literature DB >> 32210560

Development of Dual Functional Nucleic Acid Delivery Nanosystem for DNA Induced Silencing of Bcl-2 Oncogene.

Somayeh Karimi1, Mohamad Hassan Fouani2, Ahmad Moshaii1, Maryam Nikkhah2, Saman Hosseinkhani3, Reza Sheikhnejad4.   

Abstract

INTRODUCTION: Cancer treatment using functionalized vehicles in order to block involved genes has attracted a remarkable interest. In this study, we investigated the cellular uptake and cytotoxic effects of three sizes of anti Bcl-2 DNAi-conjugated gold nanoparticles by MCF-7 cells.
METHODS: Three different sizes of gold nanoparticles were synthesized by citrate reduction method and after characterization, the nanoparticles were functionalized by Bcl-2 targeted DNAi. Cell internalization of the nanoparticles was analyzed by atomic absorption spectroscopy and light microscopy. The cytotoxic effects of the nanoparticles were investigated by MTT assay, flow cytometry and RT-PCR of the target gene.
RESULTS: While poor cell internalization of bare gold nanoparticles was observed, the results demonstrated that cellular uptake of DNAi-conjugated gold nanoparticles is completely size-dependent, and the largest nanoparticle (~42 nm) revealed the highest internalization rate compared to other sizes (~14 and ~26 nm). Experimental findings showed that the DNAi-conjugated gold nanoparticles induced apoptotic pathway by silencing of the targeted Bcl-2 gene. In addition, supplementary theoretical studies demonstrated that the 42 nm DNAi-conjugated gold nanoparticles have great photothermal conversion efficiency for treatment under external illumination and these nanoparticles can be induced further cytotoxic effect by approximately 10°C temperature elevations.
CONCLUSION: Remarkable photothermal properties of DNAi-conjugated 42 nm Au-NPs in parallel with their high cell internalization and cytotoxic effects introduce them as potential dual functional anticancer nanosystems.
© 2020 Karimi et al.

Entities:  

Keywords:  Bcl-2; DNAi; apoptosis; breast cancer; gold nanoparticles

Mesh:

Substances:

Year:  2020        PMID: 32210560      PMCID: PMC7073599          DOI: 10.2147/IJN.S236217

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  61 in total

1.  Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration.

Authors:  J Bonadio; E Smiley; P Patil; S Goldstein
Journal:  Nat Med       Date:  1999-07       Impact factor: 53.440

2.  Functional long-range interactions of the IgH 3' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells.

Authors:  H Duan; H Xiang; L Ma; L M Boxer
Journal:  Oncogene       Date:  2008-08-11       Impact factor: 9.867

Review 3.  Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy.

Authors:  Peter E Czabotar; Guillaume Lessene; Andreas Strasser; Jerry M Adams
Journal:  Nat Rev Mol Cell Biol       Date:  2014-01       Impact factor: 94.444

4.  Kinetically controlled seeded growth synthesis of citrate-stabilized gold nanoparticles of up to 200 nm: size focusing versus Ostwald ripening.

Authors:  Neus G Bastús; Joan Comenge; Víctor Puntes
Journal:  Langmuir       Date:  2011-07-29       Impact factor: 3.882

5.  Assembly of polyethylenimine-based magnetic iron oxide vectors: insights into gene delivery.

Authors:  Maria Arsianti; May Lim; Christopher P Marquis; Rose Amal
Journal:  Langmuir       Date:  2010-05-18       Impact factor: 3.882

6.  Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine.

Authors:  Prashant K Jain; Kyeong Seok Lee; Ivan H El-Sayed; Mostafa A El-Sayed
Journal:  J Phys Chem B       Date:  2006-04-13       Impact factor: 2.991

7.  A comparison of gold nanoparticle surface co-functionalization approaches using Polyethylene Glycol (PEG) and the effect on stability, non-specific protein adsorption and internalization.

Authors:  Emma Harrison; James R Nicol; Manuel Macias-Montero; George A Burke; Jonathan A Coulter; Brian J Meenan; Dorian Dixon
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2016-02-08       Impact factor: 7.328

8.  Inhibition of HIV fusion with multivalent gold nanoparticles.

Authors:  Mary-Catherine Bowman; T Eric Ballard; Christopher J Ackerson; Daniel L Feldheim; David M Margolis; Christian Melander
Journal:  J Am Chem Soc       Date:  2008-05-13       Impact factor: 15.419

9.  Size-dependent endocytosis of gold nanoparticles studied by three-dimensional mapping of plasmonic scattering images.

Authors:  Sheng-Hann Wang; Chia-Wei Lee; Arthur Chiou; Pei-Kuen Wei
Journal:  J Nanobiotechnology       Date:  2010-12-20       Impact factor: 10.435

10.  Development of a Biocompatible Copolymer Nanocomplex to Deliver VEGF siRNA for Triple Negative Breast Cancer.

Authors:  Zhen Zhao; Yuanke Li; Ravi Shukla; Hao Liu; Akshay Jain; Ashutosh Barve; Kun Cheng
Journal:  Theranostics       Date:  2019-06-09       Impact factor: 11.556

View more
  4 in total

Review 1.  Multifunctional Gold Nanoparticles in Cancer Diagnosis and Treatment.

Authors:  Yan Yang; Xi Zheng; Lu Chen; Xuefeng Gong; Hao Yang; Xingmei Duan; Yuxuan Zhu
Journal:  Int J Nanomedicine       Date:  2022-05-06

2.  Radiosensitization of breast cancer cells using AS1411 aptamer-conjugated gold nanoparticles.

Authors:  Somayeh Sadat Mehrnia; Bijan Hashemi; Seyed Javad Mowla; Maryam Nikkhah; Azim Arbabi
Journal:  Radiat Oncol       Date:  2021-02-10       Impact factor: 3.481

3.  Silencing of MEF2D by siRNA Loaded Selenium Nanoparticles for Ovarian Cancer Therapy.

Authors:  Changbing Wang; Yu Xia; Shaochuan Huo; Diwen Shou; Qing Mei; Wenjuan Tang; Yinghua Li; Hongsheng Liu; Yongjian Zhou; Bing Zhu
Journal:  Int J Nanomedicine       Date:  2020-12-04

Review 4.  Gold Nanoparticles for Vectorization of Nucleic Acids for Cancer Therapeutics.

Authors:  Daniela Ferreira; David Fontinha; Catarina Martins; David Pires; Alexandra R Fernandes; Pedro V Baptista
Journal:  Molecules       Date:  2020-07-31       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.